Predictors of response to serotonin reuptake inhibitors in obsessive-compulsive disorder

被引:29
作者
Hazari, Nandita [1 ]
Narayanaswamy, Janardhanan C. [1 ]
Arumugham, Shyam Sundar [1 ]
机构
[1] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Psychiat, OCD Clin, Hosur Rd Bangalore, Bangalore 560029, Karnataka, India
关键词
Obsessive compulsive disorder; serotonin reuptake inhibitors; treatment outcome; pharmacological; biomarker; CLINICAL PREDICTORS; CLOMIPRAMINE TREATMENT; DRUG RESPONSE; PHARMACOLOGICAL-TREATMENT; FLUOXETINE TREATMENT; BEHAVIORAL-THERAPY; SYMPTOM DIMENSIONS; WHOLE-BLOOD; TNF-ALPHA; FOLLOW-UP;
D O I
10.1080/14737175.2016.1199960
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: 40-60% of patients with obsessive compulsive disorder (OCD) do not respond adequately to serotonin reuptake inhibitors (SRIs). It is important to identify predictors of response to help individualize treatment and identify refractory patients early in the course of treatment.Areas covered: We review the current literature on predictors of response to SRIs in adult patients with OCD including clinical features, neuropsychological profile, neuroimaging, genetics and other biological factors. We conducted a literature search in PUBMED database using the MeSH terms Obsessive-Compulsive Disorder', drug therapy', treatment outcome', neuroimaging', genetics' cytokines' and obtained 60 articles.Expert commentary: Poor-insight into obsessions, symmetry/hoarding and contamination/washing dimension and the presence of certain personality disorders are associated with poor response to SRIs. Orbitofrontal cortex, anterior cingulate cortex, caudate, putamen and thalamus volume changes in structural imaging studies and altered activity in the same regions in functional imaging studies were found predictive of poor response. However, there is inconsistency with regards to direction of change. Genes involving serotonergic and glutamatergic signalling pathways have emerged as predictors in recent studies. Studies with large sample size, standardised methodology and rigorous statistical analyses are required before predictors can be utilised in routine clinical practice.
引用
收藏
页码:1175 / 1191
页数:17
相关论文
共 108 条
[1]   The neuropsychology of adult obsessive-compulsive disorder: A meta-analysis [J].
Abramovitch, Amitai ;
Abramowitz, Jonathan S. ;
Mittelman, Andrew .
CLINICAL PSYCHOLOGY REVIEW, 2013, 33 (08) :1163-1171
[2]   Side effects as predictors of drug response in obsessive-compulsive disorder [J].
Ackerman, DL ;
Greenland, S ;
Bystritsky, A .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) :459-465
[3]  
ACKERMAN DL, 1994, J CLIN PSYCHOPHARM, V14, P247
[4]   Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder [J].
Ackerman, DL ;
Greenland, S ;
Bystritsky, A .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (03) :185-192
[5]   Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy [J].
Alonso, P ;
Menchon, JM ;
Pifarre, J ;
Mataix-Cols, D ;
Torres, L ;
Salgado, P ;
Vallejo, J .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (07) :535-540
[6]   Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder [J].
Alonso, Pino ;
Gratacos, Monica ;
Segalas, Cinto ;
Escaramis, Georgia ;
Real, Eva ;
Bayes, Monica ;
Labad, Javier ;
Lopez-Sola, Clara ;
Estivill, Xavier ;
Menchon, Jose M. .
JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2012, 37 (04) :273-281
[7]  
[Anonymous], 1994, J. Clin. Psychiatry
[8]  
[Anonymous], 1997, J CLIN PSYCHIAT S4, V58, P2
[9]   Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study [J].
Arnold, PD ;
Rosenberg, DR ;
Mundo, E ;
Tharmalingam, S ;
Kennedy, JL ;
Richter, MA .
PSYCHOPHARMACOLOGY, 2004, 174 (04) :530-538
[10]   Commonly asked questions in the treatment of obsessive-compulsive disorder [J].
Arumugham, Shyam Sundar ;
Reddy, Y. C. Janardhan .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (02) :151-163